ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 5509

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 6280

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 6718

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: S.1031

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: S.1816

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: S. 2903

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: S. 3607

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and the Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Healthcare Workforce improvement; 8) H.R. 6718 the Professional Student Degree Act (to endorse, not yet communicated to sponsors office); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Support appropriations for strong NIH funding; 16) Planning and coalition work for advocacy on supportive cancer care, including efforts to get language in Senate appropriations bill relating to benefits and costs of such care; 17) Clinical Trial Modernization Act (HR 3521/S. 4440); 18) Proposals to reform the 340B program (Senate); 19) Request that Congressional appropriating committees oppose the implementation of the Office of Management and Budget (OMB) Uniform Guidance.

Client expense: $10,000 · Firm income: —

Matched citations: S. 4440

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 2120

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 3514

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: HR 3521

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: H.R.4299

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 5509

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 6280

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: H.R. 6718

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: HR 8839

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: S.1031

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: S.1816

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: S. 2793

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: S. 2903

Health care priorities of ACCC: 1) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 3) Financial toxicity for cancer patients; 4) Drug Pricing: Inflation Reduction Act implementation, Senate Finance Minority Drug Pricing RFI, and especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 5) Reducing Physician Payment Reimbursement Cuts; 6) Healthcare Workforce improvement, including re: streamlining visa processing and administration for international medical professionals, graduates, and students; 7) H.R. 6718 the Professional Student Degree Act; 8) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 9) Safe Step Act (H.R. 5509/S. 2903); 10) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 11) Issues related to coverage (including renewal of ACA subsidies and mitigating impact of Medicaid changes in OBBBA); 12) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 13) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 14) Request to Designate April as Cancer Prevention and Early Detection month; 15) Modernize incentives for Advanced Alternative Payment Models (APMs); 16) Stabilize physician payment system and prepare for APMs; 17) Leverage the CMS Innovation Center; 18) Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; 19) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization; 20) Appropriations for NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.

Client expense: $10,000 · Firm income: —

Matched citations: S. 3607